Naheed Rohman Mirza

Naheed (MAX) Rohman Mirza is a distinguished professional in the field of neuroscience and pharmacology, currently serving as a Strategic Advisor at Neurvati Neurosciences and as VP of Neuroscience Drug Discovery at Sygnature Discovery. With a robust background, Naheed held several key positions including Executive Director of Early Development Pain & CNS at Mundipharma, Senior Director of External R&D Innovation at Pfizer, and CSO & Co-Founder at Saniona. Naheed's earlier career included significant roles at NeuroSearch A/S and as a Senior Researcher at the Policy Research Institute on Ageing and Ethnicity, focusing on issues of dementia care for minority ethnic elders. Educationally, Naheed earned a Ph.D. in Psychiatry/Cognition from the Institute of Psychiatry and Oxford University, an MSc in Alzheimer's disease from the University of Bristol, and a BSc in Human Physiology & Zoology from the University of London.